Moncrieff J, Kirsch I
Add-Ons: Labs ($129), additional therapies available after initial consultation including enclomiphene, nandrolone, tadalafil, BPC-157, L-carnitine, B12 MIC, oxandrolone, HCG, phentermine, and hexarelin
Semaglutide is a GLP-1 receptor agonist with a well-established safety record and extensive clinical data
Excessive load creates re-injury risk, especially in the early pain-free window
According to a Cochrane analysis, although some beneficial effects on pain and improvement in vibration perception threshold have been reported, no conclusive evidence has been found to support a significant reduction in pain after 612 months of treatment with acetyl-L-carnitine in patients with DPN [111]